Karina Dalsgaard Sørensen

DNA methylation signatures for prediction of biochemical recurrence after radical prostatectomy of clinically localized prostate cancer

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  • Christa Haldrup, Denmark
  • Kamilla Mundbjerg, Denmark
  • Else Marie Vestergaard
  • Philippe Lamy
  • Peter Wild, Institute of Surgical Pathology, University Hospital Zurich, Switzerland
  • Wolfgang A Schulz, Department of Urology, Heinrich Heine University, Germany
  • Christian Arsov, Department of Urology, Heinrich Heine University, Germany
  • Tapio Visakorpi, Department of Urology, Tampere University Hospital, Finland
  • Michael Borre
  • Søren Høyer, Department of Pathology, Aarhus University Hospital, Denmark
  • Torben F Orntoft
  • Karina D Sørensen
Diagnostic and prognostic tools for prostate cancer (PC) are suboptimal, causing overtreatment of indolent PC and risk of delayed treatment of aggressive PC. Here, we identify six novel candidate DNA methylation markers for PC with promising diagnostic and prognostic potential.
Original languageEnglish
JournalJournal of Clinical Oncology
Pages (from-to)3250-8
Number of pages9
Publication statusPublished - 10 Sep 2013

    Research areas

  • Aged, Case-Control Studies, Cohort Studies, DNA Methylation, Denmark, Finland, Follow-Up Studies, Germany, Humans, Male, Middle Aged, Neoplasm Grading, Neoplasm Recurrence, Local, Neoplasm Staging, Prognosis, Promoter Regions, Genetic, Prostatectomy, Prostatic Neoplasms, Sensitivity and Specificity, Survival Rate, Switzerland, Tumor Markers, Biological, Validation Studies as Topic

See relations at Aarhus University Citationformats

ID: 68552411